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Production of interleukin (IL)-10, a major immu-
noregulatory cytokine, by phagocytes during
clearance of apoptotic cells is critical to ensur-
ing cellular homeostasis and suppression of
autoimmunity. Little is known about the regula-
tory mechanisms in this fundamental process.
We report that IL-10 production stimulated by
apoptotic cells was regulated at the point of
transcription in a manner dependent on p38
mitogen-activated protein kinase, partially on
the scavenger receptor CD36, and required
cell-cell contact but not phagocytosis. By using
a reporter assay, we mapped the apoptotic-
cell-response element (ACRE) in the human
IL10 promoter and provide biochemical and
physiological evidence that ACRE mediates
the transcriptional activation of IL10 by pre-B
cell leukemia transcription factor-1b and an-
other Hox cofactor Pbx-regulating protein 1 in
response to apoptotic cells. This study estab-
lishes a role of two developmentally critical
factors (Pbx1 and Prep-1) in the regulation of
homeostasis in the immune system.
INTRODUCTION
Inmulticelluar organisms, large numbers of apoptotic cells
are generated during development, tissue remodeling,
and inflammation (Aderem and Underhill, 1999). The reso-
lution of inflammation is a dynamically regulated process
that involves the suppression of proinflammatory gene
expression, leukocyte migration, and activation followed
by clearance of apoptotic cells by phagocytosis. Profes-
sional phagocytes such as monocytes, macrophages,952 Immunity 27, 952–964, December 2007 ª2007 Elsevier Incand neutrophils efficiently phagocytose apoptotic cells
to prevent inflammation.
The major difference with respect to phagocytic capac-
ity and efficiency of professional and nonprofessional
phagocytes is the number of different phagocytic recep-
tors present on professional phagocytes (Aderem and
Underhill, 1999). Macrophages, in particular, contain
a myriad of phagocytic receptors that interact with apo-
ptotic cells. This includes complement receptors, Fc re-
ceptors, integins (avb3, avb5), scavenger receptors (SRA,
CD36, CD14, and LOX-1), and the presumptive phospha-
tidylserine receptor (PSR) (Stuart and Ezekowitz, 2005).
These receptors interact with their ligands on the surface
of the apoptotic cells directly or via bridging proteins.
Interestingly, macrophages use the same receptors to
recognize both apoptotic cells and pathogens (Stuart
and Ezekowitz, 2005). An inflammatory response occurs
when macrophages phagocytose pathogens. In contrast,
macrophage recognition of apoptotic cells triggers an
anti-inflammatory response, which is mediated by the re-
lease of interleukin (IL)-10, transforming growth factor
(TGF)-b, platelet-activating factor (PAF), and prostaglan-
din E2 (PGE2) with concurrent inhibition of TNF-a, IL-12,
IL-1b, and IL-8 (Voll et al., 1997b). Furthermore, it has
been recently demonstrated that the profound suppres-
sion of lipopolysaccharides (LPS)-driven TNF-a release
by macrophages requires contact-dependent licensing
of phagocytic cell responsiveness to TGF-b by apoptotic
cells (Lucas et al., 2006). Both the removal of apoptotic
cells and the active suppression of inflammatory cyto-
kines are required for preventing chronic inflammation
and autoimmune disorders such as systemic lupus eryth-
ematosus (SLE) (Casciola-Rosen et al., 1996; Herrmann
et al., 1998; Walport and Lachmann, 1990), retinitis pig-
mentosa (Camenisch et al., 1999; Gal et al., 2000), and
cystic fibrosis (Camenisch et al., 1999; Gal et al., 2000).
IL-10 is an important immunoregulatory cytokine origi-
nally discovered as a product of T helper (Th)2 cells for
suppressing cytokine production by Th1 cells (Fiorentino.
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macrophages also produce IL-10 (de Waal Malefyt et al.,
1991a; Hsu et al., 1992). Studies of numerous inflamma-
tory disease models including chronic enterocholitis, cu-
taneous inflammatory condition, endotoxic shock and
Shwartzman reaction, and autoimmune encephalomyeli-
tis in IL-10-deficient mice provided strong indications
that IL-10 plays a central role in vivo in restricting inflam-
matory responses (Berg et al., 1995a; Berg et al., 1995b;
Bettelli et al., 1998; Fuss et al., 2002; Kuhn et al., 1993).
IL10 gene expression in macrophages is usually trig-
gered by the same typical inflammatory stimuli such as
LPS that induce the release of proinflammatory cytokines.
However, the kinetics of its induction differs from those of
the proinflammatory mediators (de Waal Malefyt et al.,
1991b; de Waal Malefyt et al., 1991c; Yssel et al., 1992).
LPS-induced IL-10 production is dependent on the sig-
naling cascade of p38 not p42 (also called extracellular-
signal-regulated kinase 1 or ERK1) mitogen-activated
protein kinase (MAPK) (Foey et al., 1998). In contrast, zy-
mosan, a stimulus for Toll-like receptor (TLR)2 and dec-
tin-1, induces dendritic cells (DCs) to secrete abundant
IL-10 but little IL-6 and IL-12 in a mechanism dependent
on TLR2- and dectin-1-mediated activation of ERK (Dillon
et al., 2006). In macrophages, the activation of ERK after
Fcg receptor ligation by immune complexes leads to a re-
modeling of the chromatin at the IL10 locus, thereby mak-
ing it more accessible to transcription factors (Lucas et al.,
2005). Recent molecular analyses of the mouse Il10 pro-
moter show that Il10 transcription in macrophage cell
types can be regulated by constitutive and ubiquitous
transcription factors such as Sp1 and Sp3, suggesting
that IL-10 might be produced at low amounts constitu-
tively so that a certain degree of control over ‘‘baseline’’ in-
flammation could be maintained (Brightbill et al., 2000;
Tone et al., 2000). A critical role for Stat3 but not other
Stat proteins in LPS-induced IL-10 transcription in a hu-
man B cell line was reported by Benkhart et al. who dem-
onstrated a direct interaction of Stat3 with the human IL10
promoter at 120 (Benkhart et al., 2000b). The role of
Stat3 as the mediator of autoinduction of IL-10 by IL-10
is also corroborated in huma monocyte-derived macro-
phages (Staples et al., 2007).
Voll et al. first observed increased IL-10 and decreased
proinflammatory cytokines (TNF-a, IL-1b, and IL-12) in
LPS-activated human peripheral blood mononuclear cells
(PBMCs) after exposure to apoptotic peripheral blood
lymphocytes (PBLs) (Voll et al., 1997a). Byrne et al.
observed increased IL-10 and TGF-b production along
with decreased TNF-a amounts from human monocytes
upon simultaneous treatment with LPS and apoptotic
human neutrophils (Byrne and Reen, 2002).
Our group previously demonstrated that during phago-
cytosis of apoptotic T cells, macrophages display pro-
found incapacity to produce IL-12. Furthermore, apopto-
tic-cell-derived signals trigger dephosphorylation and
activation of a nuclear zinc-finger-like protein, named
GC-binding protein (GC-BP), which targets a specific
site in the promoter of the gene encoding IL-12 p35,Imthereby preventing its transcription (Kim et al., 2004).
The objective of the present study was to elucidate the
molecular mechanisms involved in the regulation of
IL10 gene expression in macrophages upon interaction
with apoptotic cells. We found that CD36 plays an im-
portant but not exclusive role in this process through
the activation of three members of the TALE (three-
amino-acid loop extension) family of homeodomain
proteins with previously known roles only in embryonic
development.
RESULTS
Macrophages Produce Large Amounts of IL-10
in Response to Apoptotic Cells
In this study, we first demonstrated direct induction of
IL-10 in murine peritoneal macrophages and human
monocyte-derivedmacrophages (HMDMs) after exposure
to apoptotic cells. Apoptotsis of Jurkat T cells and autolo-
gous T lymphocytes was induced with staurosporine,
a protein kinase C (PKC) inhibitor (Tamaoki et al., 1986).
Compared to the live cells (Figure 1A, panel 1), stauro-
sporine induced increasing amounts of early apoptosis
(Annexin V+, PI) up to 6 hr (panels 2 and 3), whereas
extended incubation resulted in ‘‘secondary necrosis’’
marked by the reduction in the Annexin V+, PI population
and increase in Annexin V+, PI+, and Annexin V, PI+ cells
(panel 4). We chose to use the 6-hr-treated cells for all
subsequent experiments.
We compared the kinetics of apoptotic cell versus
LPS-induced IL-10 protein production from HMDMs
(Figure 1B). The degree of LPS-induced IL-10 from
HMDMs was substantially greater compared to apoptotic
T cell- or autologous T cell-induced IL-10. Apoptotic
Jurkat T cells were able to induce IL-10 production by 4
hr after stimulation, and this amount of cytokine produc-
tion increased from 8 hr to 24 hr after stimulation. Autol-
ogous T cells induced less but similar pattern of IL-10
protein production as apoptotic Jurkat T cells. We also
compared the kinetics of apoptotic-cell- versus LPS-
induced IL-10 production from murine peritoneal macro-
phages (Figure 1C). Unstimulated macrophages pro-
duced little IL-10 at all time points. LPS induced IL-10
production gradually from 4 to 48 hr after stimulation.
Apoptotic Jurkat T cells were able to induce high levels
of IL-10 production by 4 hr and peaked at 8 hr after
stimulation. Autologous apoptotic splenic CD4+ T cells
induced less IL-10 production compared with apoptotic
Jurkat T cells on a per-cell basis but the pattern of induc-
tion was very similar.
Because the apoptotic cell population were undergoing
early apoptosis and contained 25% live cells and some
necrotic cells (Figure 1A), they could also have an impact
on IL-10 production when macrophages were exposed to
a mixture of these cells. Thus, we assessed the effect of
live and necrotic cells in RAW264.7 mouse macrophage-
like cell line and murine peritoneal macrophages. No
IL-10 was produced when peritoneal macrophages were
stimulated with live or necrotic cells derived from Jurkatmunity 27, 952–964, December 2007 ª2007 Elsevier Inc. 953
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Regulation of IL-10 Production by Apoptoic CellsFigure 1. Macrophages Produce IL-10 in Response to Apoptotic Cells
(A) Apoptosis of Jurkat cells was induced 0, 3, 6, and 12 hr. The percentage of early- and late-apoptotic cells was quantified by flow cytometry analysis
with Annexin V and propidium iodide (PI) staining. The numbers indicate percentages of the subpopulations.
(B–D) A total of 0.5 3 105 thioglycollate-elicited peritoneal macrophages (C and E), HMDM (B), or RAW264.7 cells (D) were stimulated with LPS
(0.5 mg/ml), apoptotic Jurkat cells, autologous apoptotic CD4+ T cells (AC), live cells (LC), or necrotic cells (NC) (2:1 ratio of AC, LC or NC to macro-
phages) for indicated times and analyzed for IL-10 production.
(E) BALB/c mice (three per group) were injected i.v. with apoptotic or necrotic Jurkat cells at doses of 23 106 and 106 cells/mouse. Blood were col-
lected, and sera were obtained 4 and 8 hr after the injections. Serum IL-10 amounts weremeasured by ELISA. The following abbreviations were used:
JKT AC, apoptotic Jurkat T cells (used in [B]–[E]) and autologous AC, apoptotic splenic CD4+ T cells (B) or purified human blood CD4+ T cells (C). All
data are presented as mean ± SD from a minimum of three individual donors.T cells or splenic CD4+ T cells (data not shown). In
RAW264.7 cells, live or necrotic Jurkat T cells induced
much less IL-10, compared to apoptotic cells (Figure 1D).
The low amounts of IL-10 induced by live cells could be
due to the presence of small amounts of apoptotic cells
(7%) in the ‘‘live’’ cell population (Figure 1A). Apoptotic
or live Jurkat T cells by themselves did not induce any
detectable IL-10 (Figure 1D).
To determine the IL-10-inducing effect of apoptotic
cells in vivo, we injected i.v. apoptotic or necrotic Jurkat
cells in two doses into mice and measured IL-10 amounts
in the serum 4 or 8 hr later. As shown in Figure 1E, apopto-
tic cells induced a potent systemic IL-10 response dose
dependently, and this response was much higher than
that by necrotic cells. The amount at 8 hr after injection
was also more than twice the amount at 4 hr, similar to
the in vitro patterns. This result demonstrates directly
the physiological response of apoptotic cells in vivo.
Subsequently, we determined that cell-cell contact
betweenapoptotic cells andmacrophages, but notphago-
cytosis, is required to induce IL-10 production (Figure S1
available online) and that apoptotic cells regulate IL-10 ex-
pression primarily at the point of transcription (Figure S2).954 Immunity 27, 952–964, December 2007 ª2007 Elsevier IncTaken together, these data demonstrate that apoptotic
cells can induce IL10 gene expression in macrophages
in vitro and in vivo.
p38 MAPK Is Crucial for Apoptotic-Cell-Induced
IL10 Transcription and Protein Production
MAPKs are serine and threonine protein kinases, which
include the p42 and p44 ERKs, the p54 and p46 JNK1
and JNK2 stress-activated protein kinase, and p38
MAPK (Lewis et al., 1998). These three families of MAPK
form three parallel signaling cascades activated by a dis-
tinct and sometimes overlapping set of stimuli (Lewis
et al., 1998). It has been shown that LPS-induced p38
MAPK regulates IL-10 synthesis through activation of
Sp1 in human monocytes (Ma et al., 2001). We hypothe-
sized that MAPK, and in particular the p38 MAPK, might
regulate apoptotic-cell-induced IL10 gene transcription or
protein production. To address this question, we treated
RAW264.7 cells with a pyridinyl imidazole compound,
SB203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-
5-(4-pyridyl) imidazole), which specifically inhibits p38
MAPK with no detectable effect on the activity on the.
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1995; Lee and Young, 1996).
RAW264.7 cells transiently transfected with the human
IL10 promoter luciferase reporter construct were treated
with SB203580 1 hr prior to apoptotic cell stimulation.
Luciferase activity was assayed 8 hr after apoptotic cell
stimulation. SB203580, at 5 mM, inhibited apoptotic-cell-
induced hIL10 promoter activity by 50% (Figure 2A).
Doses greater than 5 mM were not used because these
concentrations were cytotoxic (Ma et al., 2001). The role
of p38 MAPK on apoptotic-cell-induced IL-10 production
fromRAW264.7 cells was also investigated.Macrophages
were treated with the drug 1 hr prior to apoptotic cell
stimulation. Cell supernatants were harvested 12 hr after
stimulation for analysis of IL-10 production. SB203580 at
1.25 mM inhibited apoptotic-cell-induced IL-10 protein
production by 70%, whereas an inactive analog of the
chemical, SB202474, did not have such an inhibitory
effect (Figure 2B). SB203580 at all concentrations totally
inhibited apoptotic-cell-induced IL-10 production in
mouse peritoneal macrophages (Figure 2C) and in primary
peripheral blood-derived human monocytes (Figure 2D).
Furthermore, SB203580, but not SB202474, similarly
inhibited LPS-induced IL-10 production in RAW264.7 cells
in a dose-dependent manner (Figure 2E).
These data indicate that p38 MAPK is important for
apoptotic-cell-induced IL10 transcription and protein
production.
Apoptotic-Cell-Induced p38 MAPK Activation
Is Partially Dependent on CD36
Clearance of apoptotic cells can be mediated by scaven-
ger receptors (SRs).These include the class SR-A, SR-B1,
oxidized low-density lipoprotein receptor-1, and CD36
(Oka et al., 1998; Platt et al., 1996; Savill et al., 1992).
CD36, one of the first macrophage receptors to be impli-
cated in the recognition of apoptotic cells (Ren et al.,
1995; Savill et al., 1992), was first characterized in the con-
text of lipoprotein metabolism, foam cell formation, and
atherosclerosis (Savill et al., 1992). CD36 has been identi-
fied as a necessary cofactor in PS-mediated recognition
of apoptotic cells (Fadok et al., 1998).
To determine the role of CD36 in apoptotic-cell-induced
IL-10 production, we compared apoptotic-cell-induced
IL-10 production kinetically between wild-type and
Cd36/ peritoneal macrophages (Figure 3A). LPS-
induced IL-10 production in wild-type and Cd36/
macrophages increased gradually from 4 to 48 hr after
stimulation.
Compared to thewild-type,Cd36/macrophages pro-
duced significantly lower amounts of LPS-induced IL-10
at 4 and 8 hr (indicated by an asterisk) but reached the
wild-type amounts by 24 hr. This implies that CD36 signal-
ing is perhaps important during the initial time course of
LPS-induced IL-10 production.
Apoptotic cells stimulated IL-10 production with a more
rapid kinetics compared to LPS. Apoptotic cells stimu-
lated large amounts of IL-10 by 4 hr and peaked at 8 hr af-
ter stimulation. At all time points measured,Cd36/mac-Imrophages produced statistically lower amounts (50%
less, p < 0.01) of apoptotic-cell-induced IL-10 when com-
pared to the wild-type, suggesting that CD36 is involved
in apoptotic-cell-induced IL-10 production. In addition to
IL-10, TNF-a was also measured (Figure 3B). Unstimu-
lated and apoptotic-cell-stimulated macrophages pro-
duced no TNF-a at all time points. Conversely, LPS
induced large amounts of TNF-a from both wild-type
and Cd36/ macrophages by 4 hr and increased gradu-
ally over the 48 hr period. There were no statistical differ-
ences in LPS-induced TNF-a production between wild-
type and Cd36/ macrophages at all time points. These
Figure 2. p38 MAPK Is Crucial for Apoptotic-Cell-Induced
IL10 Promoter and Protein Production
(A) Human IL10 promoter (129 to +30) construct was transfected into
RAW264.7 cells as described in Figure S2. Cells were treated with
SB203580 under the indicated concentrations 1 hr prior to apoptotic
cell stimulation. Control cells received DMSO instead of the drug.
(B–E) A total of 0.53 105 RAW264.7 cells (B and E) or 0.53 105 mouse
peritoneal macrophages (C) and primary human monocytes (D) were
treatedwith SB203580 or SB202474 (B and E) at the indicated concen-
trations 1 hr prior to apoptotic cell stimulation (2:1 ratio of apoptotic
cells/macrophages) or LPS (E). The supernatants were harvested after
12 hr and analyzed for IL-10 production. All data were presented as
mean ± SD from three independent experiments.munity 27, 952–964, December 2007 ª2007 Elsevier Inc. 955
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(A and B) 0.5 3 105 WT and Cd36/ peritoneal macrophages were stimulated with either LPS or apoptotic Jurkat T cells (AC) for indicated times.
Supernatants were analyzed for mouse IL-10 (A) and TNF-a production (B).
(C and D)Cd36/ and control C57BL/6mice (three per group) were injected i.v. with 107 apoptotic Jurkat cells. Eight hours later, 0.53 106 peritoneal
macrophages (C) were collected and cultured for 24 hr without further stimulation, and IL-10 was measured by ELISA. For (D), peritoneal exudates in
these mice were also collected for mouse IL-10 measurement. The values represent the amount of IL-10 in the entire peritoneal exudates of each
individual mouse.
(E) A total of 0.53 105 RAW264.7cells were stimulated with apoptotic Jurkat T cells (AC) for 12 hr. Oxidized-LDL (ox-LDL) were added simultaneously
with apoptotic cells at various concentrations as indicated. Cell-free supernatants were analyzed for mouse IL-10 production.
(F and G) Whole-cell lysate were harvested from 2 3 106 wild-type and Cd36/ peritoneal macrophages under the conditions indicated. Proteins
were subject to SDS-PAGE analysis on a 10% polyacrylamide gel and probed with antibodies against total p38, phosphorylated p38, and phosphor-
ylated ERK. The following abbreviations are used: SB, SB203580 was used at 25 mM; DS, dimethyl sulfoxide, the medium in which SB203580 was
dissolved. All data were presented as mean ± SD from three independent experiments. *p < 0.05; **p < 0.01; and ***p < 0.001 between wild-type and
CD36 KO cells.results imply that CD36 is not involved in the LPS signaling
pathway for TNF-a production.
To determine the physiological importance of CD36 in
apoptotic-cell-induced IL-10 production, we injected apo-
ptotic Jurkat cells into Cd36/ mice i.v., then measured
IL-10 secretion directly from resident macrophages in
the peritoneal cavity (Figure 3C) and from the exudates
(Figure 3D). Apoptotic cells induced a substantial amount
of IL-10 from the macrophages in the peritoneum, an
amount that was reduced in Cd36/ mice. The degree
of reduction was very similar to the in-vitro-induced
IL-10 amounts in Cd36/ macrophages (Figure 3A).
Oxidized-LDL (ox-LDL) is one of the physiological
ligands for CD36 (Rigotti et al., 1995). However, in our
model, ox-LDL alone had no IL-10-inducing activity,
although it inhibited apoptotic-cell-induced IL-10 protein
production (Figure 3E). Therefore, ox-LDL appears to
function as an antagonist of apoptotic cell induction of
IL-10 production, possibly through interference of
CD36’s interaction with apoptotic cells.956 Immunity 27, 952–964, December 2007 ª2007 Elsevier IncThe above results demonstrated that both p38 MAPK
and CD36 are important for apoptotic-cell-induced IL-10
gene expression. We then addressed the role of CD36 in
apoptotic-cell-induced p38 MAPK activation. Wild-type
and Cd36/ peritoneal macrophages were stimulated
with LPS, necrotic cells, and apoptotic cells with or with-
out SB203580 over a period of 6 hr. Whole-cell lysates
were subject to immunoblot analysis with antibodies
against phosphorylated p38 and phosphorylated ERK
(Figures 3F and 3G). The amount of LPS-induced p38
MAPK activation was similar between wild-type and
Cd36/ macrophages, indicating that LPS-induced p38
MAPK activation does not depend onCD36. Necrotic cells
were not able to activate p38 MAPK but activated ERK
in wild-type cells and in Cd36/ cells, albeit to a lower
degree. Compared with wild-type macrophages, apopto-
tic-cell-induced p38MAPK activation was substantially re-
duced in Cd36/ macrophages. These results indicate
apoptotic-cell-induced p38 MAPK activation is at least
partially dependent on CD36. SB203580, at 25 mM, had.
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Regulation of IL-10 Production by Apoptoic CellsFigure 4. The Apoptotic-Cell-Response Element, ACRE, Is Located from 106 to 98 in the Human IL10 Promoter
(A) The full-length human IL10 promoter (1044 to +30) and various 50 and 30 truncation constructs linked to the firefly luciferase reporter gene were
transiently transfected into RAW264.7 cells. Next day, cells were stimulated with apoptotic Jurkat T cells. Luciferase activity was measured 8 hr after
stimulation. Data are expressed as fold induction relative to RAW264.7 cells not treated with apoptotic cells and represent three independent exper-
iments with SD. Student’s t test was used for statistical analysis of the comparison between two groups (specified by a bracket). *p < 0.05; **p < 0.01.
(B and C) Response of the human IL10 promoter (129 to +30) construct containing either the wild-type Pbx-1-binding site or its substitution mutant
to apoptotic cells (C) or to LPS (D). The difference in LPS response between the two constructs in (D) was not statistically significant. Base substi-
tutions were made by transversion.
(D) Response of the human IL-10 promoter (129/+30) construct (reporter) containing either the wild-type Pbx-1-binding site or its substitution
mutant cotransfected with Pbx-1a and 1b expression vector (effector) or control vector pcDNA3.1 into RAW264.7 cells by electroporation at molar
ratios of 1.75:1 or 2:1 (effector:reporter). The next day, cells were stimulated with apoptotic Jurkat T cells. Luciferase activity was measured 8 hr after
stimulation.
(E) An experiment with design identical to (D) was carried out with two additional Hox factors, Meis-1 and Prep-1, in a molar ratio of Pbx-1b:Meis-
1:Prep-1 = 1:1:1.little effect on ERK phosphorylation in both wild-type and
Cd36/ cells, although it partially inhibited p38MAPK ac-
tivation in both cell types.
Taken together, these results suggest that CD36 is
important physiologically but is not the only receptor for
apoptotic-cell induced-IL-10 and that p38 MAPK activa-
tion is partially dependent on CD36.
An Apoptotic-Cell-Response Element Is located
at 106/98 in the IL10 Promoter
To determine the DNA sequences that mediate apoptotic-
cell-induced IL10 transcription in the IL10 promoter, we
generated a series of 50and 30 deletion constructs of the
1042 to +30 IL10 promoter reporter. These constructs
were transiently transfected into RAW264.7 cells and
stimulatedwith apoptotic Jurkat cells, and their responses
were measured by their luciferase activities (Figure 4A).
Notably, there was a dramatic decrease in apoptotic-
cell-induced luciferase activity when the promoter was
deleted from 129 to 80, indicating the presence of
a strong positive regulatory element(s) in the 49 bp region
of the IL10 promoter.ImA computer-aided analysis revealed the existence of
consensus sequences for two transcription factors: Ets
(50-ggaa-30 at 113 to 110) and the homeodomain pro-
tein pre-B cell leukemia transcription factor-1 (Pbx-1)
(50-ttgattgtg-30 at 106 to 98). A detailed systematic
mutagenesis study of the 129 to 80 region revealed
that the sequence between 95 and 106, which over-
laps the putative Pbx-1 motif, was most critical for the
apoptotic cell response of the IL10 promoter (data not
shown). Subsequently, we introduced site-specific point
mutations into the 9 bp putative Pbx-1-binding site; this
reduced the promoter activity by80% in response to ap-
optotic cells compared to the wild-type luciferase reporter
construct (129 to +30) (Figure 4B) while having little
effect on LPS-induced promoter activity (Figure 4C), indi-
cating that this particular sequence constitutes a major
apoptotic-cell-response element (ACRE).
The Pbx homeoproteins can function as cofactors for
Hox family of homeodomain-containing transcription fac-
tors that pattern the embryonic body axes (Moens and
Selleri, 2006). Pbx-1a and Pbx-1b are the two isoforms
of Pbx-1. Pbx-1a expression is restricted to neural tissues,munity 27, 952–964, December 2007 ª2007 Elsevier Inc. 957
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in the mouse embryo (Moens and Selleri, 2006). To further
investigate the role and mechanism of Pbx-1 in the regu-
lation of IL10 transcription during phagocytosis of apopto-
tic cells, we overexpressed Pbx-1a and Pbx-1b by tran-
sient transfection in RAW264.7 cells, which increased
the apoptotic-cell-induced luciferase activity in the hIL10
promoter luciferase reporter construct (129 to +30)
(Figure 4D). The augmented effects were totally abrogated
with the IL10 promoter construct containing base substi-
tutions in the putative Pbx-1-binding site, indicating that
this sequence is crucial for the transcriptional augmenta-
tion by Pbx-1. Both Pbx-1a and Pbx-1b had little effect
on basal transcription without apoptotic cell stimulation,
suggesting that the transcriptional potential of Pbx-1a
and Pbx-1b depends on signals from apoptotic cells.
Hox proteins and some orphan homeodomain proteins
form complexes with either Pbx or Meis subclasses of
homeodomain proteins. This interaction can increase the
binding specificity and transcriptional effectiveness of
the Hox partner (Moens and Selleri, 2006). To test this
possibility on the IL10 gene, we cotransfected Pbx-1b
and two Meis proteins: Meis-1 and Pbx-regulating protein
(Prep)-1(also called Meis-4) with the IL10 reporter
(Figure 4E). Expression Meis-1 or Prep-1 individually did
not enhance Pbx-1b’s transcriptional stimulation of the
IL10 reporter, although the combination of the two factors
synergistically augmented Pbx-1b’s transcriptional po-
tency, indicating the functional interaction and coopera-
tion of these three Hox factors in the activation of IL10
gene transcription. Again, the combination of three Hox
factors had little effect on basal transcription without
apoptotic cell stimulation.
Pbx-1 Is a Selective Physiological Regulator
of IL-10 Production in Response to Apoptotic Cells
To establish the physiological role of Pbx-1 in the regula-
tion of Il10 gene expression in response to apoptotic cells,
we generated macrophages from Pbx1/ embryos. Due
to the extraordinary importance of Pbx-1 in mammalian
development, thus overwhelming embryonic lethality of
the Pbx1-deficiency (Moens and Selleri, 2006), we derived
macrophages from E14.5 embryonic liver of heterozygote
mating. Cells derived from liver of littermate embryos of
the wild-type (+/+) and heterozygous (+/) genotypes
were used as a control. By flow-cytometric analysis,
the embryonic-liver-derived macrophages were 90%
F4/80 and CD11b positive, irrespective of their Pbx1
genotypes (Figure 5A). There were equivalent amounts
of CD36 surface expression between the wild-type
and Pbx1/ macrophages (Figure 5B). Functionally,
Pbx1/ macrophages produced similar amounts of
IL-12 and TNF-a in response to LPS stimulation and sim-
ilar amounts of TGF-b in response to apoptotic cells,
whereas LPS-induced IL-6 production was increased
and apoptotic-cell-induced IL-10 production was signifi-
cantly reduced (Figure 5C). The phagocytic capacity, as
measured by ingestion of E. coli, was also similar be-
tween the two types of macrophages. No statistical differ-958 Immunity 27, 952–964, December 2007 ª2007 Elsevier Incences in LPS-stimulated IL-10 production were found
between the two groups (results not shown). These
results demonstrate that Pbx-1 plays an important and
selective physiological role in apoptotic cell-induced
IL-10 production, and its transcriptional role is uncoupled
from phagocytosis.
Blocking Pbx-1 Expression Results in Reduction
of Apoptotic-Cell-Induced IL-10 Expression
In parallel, we applied the RNAi technology to further
corroborate Pbx-1’s role in the regulation of apoptotic-
cell-induced IL-10 expression, with the prediction that
inhibiting the expression of Pbx-1 would result in sup-
pressed Il10 transcription. For this purpose, we trans-
fected a siRNA specific for Pbx-1a and Pbx-1b into
RAW264.7 cells to reduce the amount of endogenous
Pbx-1 expression. As shown in Figure 6A, Pbx-1b, Pbx-2,
and Pbx-3 mRNA were constitutively expressed in
RAW264.7 cells, whereas Pbx-1a was not expressed (it
would have been amplified as a larger size product by
the same primers used for detecting Pbx-1b mRNA).
The Pbx-1-specific siRNA but not a control (GFP-specific)
siRNA selectively inhibited Pbx-1b mRNA expression in
a dose-dependent manner and had little effect on Pbx-2,
Pbx-3, and GAPDH mRNA expression. Accompanying
the reduction in Pbx-1 mRNA expression, IL-10 mRNA
expression was also reduced. The Pbx-1 siRNA strongly
inhibited Pbx-1b protein expression (Figure 6B).
Consistent with its ability to knock down the endoge-
nous amounts of Pbx-1, the Pbx-1 siRNA also dose de-
pendently inhibited apoptotic-cell-induced IL10 reporter
activity by as much as 60% at 200 nM, whereas the con-
trol siRNA had little effect at this concentration (Figure 6C).
Likewise, the IL-10 protein secretion from the same cells
was reduced by approximately the same degrees by the
siRNA (Figure 6D).
Taken together, these data demonstrate that Pbx-1b is
a physiologically critical mediator of apoptotic-cell-indu-
ced IL-10 gene transcription.
Characterization of DNA-Binding Activities
of Pbx-1b and Its Cofactor Prep-1
On the basis of these observations, we further hypothe-
sized that Pbx-1b might activate IL10 transcription in
response to apoptotic cells by physically interacting with
the ACRE. To test this hypothesis, we performed electro-
phoretic mobility shift assays (EMSAs) by using nuclear
extracts isolated from RAW264.7 cells and using the
ACRE sequence as the probe. As shown in Figure 7A,
apoptotic cells strongly induced a DNA-protein complex
(lane 3, indicated by an arrow). This binding activity was
partially abolished by polyclonal antibodies against Pbx-1,
Pbx-2, and Pbx-3 (lane 6) and Pbx-1 (lane 7), whereas
the isotype-matched control antibody (lane 5) and anti-
bodies against Pbx-2 (lane 8) and Pbx-3 (lane 9) had little
effect. Given the fact that Pbx-1a is not expressed in mac-
rophages, this result suggests that Pbx-1bmight physically
interact with the IL10 promoter at the ACRE site. The Pbx-1
binding activity was also observed in nuclear extracts.
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(A) Flow-cytometric analysis of in vitro generated embryonic-liver-derived mousemacrophages from littermates of wild-type (+/+) and Pbx1/mice.
The fluorescent intensity (x axis) of F480 and CD11b staining of live cells (y axis) in the cultures are shown.
(B) CD36 expression on macrophages derived from wild-type and Pbx-1 null embryos. An isotype-matched control antibody was used to set the
baseline.
(C) Reduced IL-10 production in Pbx-1-deficient embryonic-liver-derived macrophages. After in vitro culture for 7 days, embryonic-liver-derived
mousemacrophages generated from littermates of wild-type (+/+) and homozygousPbx1/mice were stimulatedwith LPS or apoptotic Jurkat cells.
Cell-free supernatant were harvested 12 hr after stimulation and assayed for various cytokine production by ELISA (pg/ml). Two asterisks denote
a statistically significant difference with a p value < 0.01. Phagocytosis of E. coli by embryonic-liver macrophages derived from wild-type Pbx1/
embryonic liver was measured and expressed as percentage of input bacteria that had been ingested. The numbers of embryos used in this exper-
iment were three wild-type and three Pbx-1 null homozygotes. All data were presented as mean ± SD from three independent experiments. Asterisks
denote a statistically significant difference with a p value <0.01.isolated from human monocytes, and HMDMs stimulated
with apoptotic cells, autologous or nonautologous, but not
with LPS (Figure S3).
To confirm direct binding of Pbx-1b to ACRE in vivo, we
performed chromatin immunoprecipitation (ChIP) assays
in RAW264.7 cells. Figure 7B shows Pbx-1-specific bind-
ing to the vicinity of the ACRE as a 214 bp amplified band,
which was slightly present in resting cells (lane 5) and
increased after apoptotic cell stimulation (lane 6, top).
The binding was site specific because it was not observed
at an irrelevant site 1.3 kb upstream of ACRE, amplified as
a 230 bp fragment (bottom).
To investigate the relationship between Pbx-1b and
CD36 engagement by apoptotic cells, we analyzed the
expression and phosphorylation of Pbx-1b in Cd36/
peritoneal macrophages stimulated with LPS or apoptotic
cells. Figure 7C shows that surprisingly, Pbx-1b expres-
sion was not altered before and after stimulation with
LPS or apoptotic cells and not altered by the CD36 defi-Imciency. Moreover, phosphorylation of Pbx-1b at tyrosine
(Y), serine (S), and threonine (T) residues was not altered
under these conditions in wild-type or Cd36/ cells.
These results indicate that CD36-mediated signaling does
not directly regulate Pbx-1 expression or phosphorylation.
Because of the functional importance of Pbx-1 dimeriz-
ing partnersMeis-1 and Prep-1 (Figure 4E), we next exam-
ined their phosphorylation. Whereas tyrosine, serine, and
threonine phosphorylation of Meis-1 was not detectable
(data not shown), threonine phosphorylation of Prep-1
was constitutive and strong but not altered by the stimuli
or CD36 deficiency (Figure 7C). In contrast, tyrosine phos-
phorylation of Prep-1 was further stimulated by apoptotic
cells but not by LPS, and moreover, it was strongly
impaired in Cd36/ cells. These results suggest that
Prep-1 is an apoptotic-cell- andCD36-regulatedmolecule
through tyrosine phosphorylation.
To further investigate the direct functional role of
cofactors Meis-1 and Prep-1 in Pbx-1b-mediated IL-10munity 27, 952–964, December 2007 ª2007 Elsevier Inc. 959
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Regulation of IL-10 Production by Apoptoic CellsFigure 6. Blocking Pbx-1 Expression Inhibits Apoptotic-Cell-Induced IL-10 Expression
(A and B) Inhibition of Pbx-1 expression by siRNA. RAW264.7 cells were transfected by Oligofectamine with siRNA specific for Pbx-1 at various
concentrations as indicated or GFP (control) at 200 nM for 4 hr and then exposed to apoptotic Jurkat cells. Eight hours later, total RNA was isolated
and subject to RT-PCR for the analysis of Pbx-1a, Pbx-1b, Pbx-2, Pbx-3, IL-10, and GAPDH mRNA expression (A). Whole-cell lysate were isolated
and subject to immunoblot analysis for Pbx-1b protein expression (B) with a polyclonal antibody for Pbx-1, Pbx-2, and Pbx-3.
(C and D) Inhibition of IL-10 expression by Pbx-1 siRNA. RAW264.7 cells were transfected with the IL10 promoter construct by electroporation.
Twelve hours later, the cells were transfected by Oligofectamine with Pbx-1 siRNA at various concentrations or the control siRNA at 200 nM for
4 hr and then exposed to apoptotic Jurkat cells. Luciferase activity (C) wasmeasured 8 hr after exposure to apoptotic cells, and IL-10 protein secretion
(D) was analyzed at 24 hr after stimulation. All data were presented as mean ± SD from three independent experiments.transcription, we performed ChIP analysis of these Hox
factors in Cd36/ macrophages. As shown in Figure 7D,
binding by all three molecules were induced to various de-960 Immunity 27, 952–964, December 2007 ª2007 Elsevier Incgrees in wild-type peritoneal macrophages encountering
apoptotic cells, whereas their binding activities were abol-
ished in the absence of CD36 (lanes 4–6), demonstratingFigure 7. Interaction of Pbx-1b and Cofactors with ACRE
(A) EMSA analysiswas performedwith ACREoligonucleotides and nuclear extracts fromRAW264.7 cells with or without stimulation by apoptotic cells
in the presence or absence of antibodies against members of the Pbx family, control IgG, or PBS.
(B) ChIP analysis of in vivo binding to the IL-10-ACRE by Pbx-1 in RAW264.7 cells under unstimulated (med) or apoptotic cell (AC)-stimulated
conditions. Control antibody (rat IgG) was used, and a 230 bp region 1.3 kb upstream of the ACRE was probed as a negative control.
(C) Whole-cell extracts were prepared from wild-type and Cd36/ peritoneal macrophages after stimulation with LPS or apoptotic cells (AC). Immu-
noprecipitation (IP) was performed with phosphotyrosine (a-pY), phosphoserine (a-pS), and phosphothreonine (a-pT) mAbs; this was followed by
immunoblotting with anti-Pbx-1 or anti-Prep-1. The relative ratios of tyrosine phosphorylation of Prep-1 are indicated below the image.
(D) ChIP analysis of in vivo binding to the IL-10-ACRE by Pbx-1, Meis-1, and Prep-1 in wild-type and Cd36/ peritoneal macrophages under unsti-
mulated (Med) or apoptotic cell (AC)-stimulated conditions. Control antibodies (mouse and rat IgG) were used as negative controls..
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with the ACRE in an apoptotic-cell- and CD36-dependent
manner.
DISCUSSION
Many phagocytic receptors are implicated in the recogni-
tion, tethering, and ingestion of apoptotic cells (Somersan
and Bhardwaj, 2001) as well as in mediating apoptotic-
cell-induced IL-10 production. In humans, the ternary
complex consisting of CD36, TSP-1, and the vitronectin
receptor (avb3) has been shown to mediate the uptake of
apoptotic cells (Lucas et al., 2006; Savill et al., 1990; Savill
et al., 1992). CD36 is involved in the differentiation of
monocytes and foam cell formation in macrophages as
a result of exposure to oxidized low-density lipid (oxLDL)
(Huh et al., 1996; Nicholson et al., 1995; Nozaki et al.,
1995). A domain (155–183) on CD36 was identified as
important in the phagocytosis of apoptotic neutrophils
(Navazo et al., 1996). Incubation of LPS-activated human
PBMCs andmonocytes with FA6-152, an agonistic mono-
clonal antibody against the TSP-1-binding site of CD36,
resulted in the production of IL-10 and the inhibition of
inflammatory cytokines TNF-a, IL-1b, and IL-12 (Voll
et al., 1997a), suggesting the anti-inflammatory effect is
achieved via CD36 interaction with TSP-1 expressed on
the surface of apoptotic cells. Although previous studies
used LPS-activated human macrophages to investigate
the role of CD36 in apoptotic-cell-induced IL-10 produc-
tion, our study took a more direct approach in examining
apoptotic-cell-induced IL-10 with respect to the role of
CD36 by using CD36-deficient macrophages. Our data
demonstrate that CD36 is responsible for 50% of
apoptotic cell-induced IL-10 production.
The evidence presented here strongly suggests that
Pbx-1b is a major physiological and selective transcrip-
tional mediator of apoptotic-cell-induced IL10 gene ex-
pression through the ACRE. Pbx proteins are composed
of Pbx-1, Pbx-2, Pbx-3, and Pbx-4 that can function as
Hox cofactors in vertebrates as they do in Drosophila
and pattern the body axes of animal embryos (Moens
and Selleri, 2006). Pbx1/ mouse embryos exhibit
profound anemia and embryonic lethality at embryonic
day 15 (E15) or E16 (DiMartino et al., 2001). Hematopoietic
stem cells from Pbx1/ embryos have reduced colony-
forming activity and are unable to establish multilineage
hematopoiesis in competitive reconstitution experiments.
Common myeloid progenitors (CMPs) are markedly de-
pleted in Pbx1/ embryos at E14 and display clonogenic
defects in erythroid colony formation (DiMartino et al.,
2001). Thus, Pbx1 is essential for the function of hemato-
poietic progenitors, and its loss creates a proliferative
block at the point of the CMP. HOX and PBX genes have
also been implicated as proto-oncogenes in human leuke-
mia. PBX1 was originally isolated as a proto-oncogene at
the site of the t(1:19) rearrangement in human pre-B acute
lymphocytic leukemia and in a small number of acute
T-lymphoid and myeloid leukemias, whereby its homeo-
domain is fused to the transcriptional activation domainsImof the immunologulin enhancer-binding protein E2a
(Kamps et al., 1990). The derived chimeric oncoprotein
retains the ability to bind DNA as a complex with Hox pro-
teins and causes aberrant proliferation of hematopoietic
progenitors and leukemic transformation (Dedera et al.,
1993; Kamps and Baltimore, 1993).
The IL-10 deficiency in Pbx-1 null macrophages
encountering apoptotic cells is not due to global develop-
mental impairment because Pbx1/-deficient embryonic
hematopoietic stem cells can differentiate normally into
macrophages indistinguishable with respect to F4/80
and CD11b expression. They exhibited no defect in their
ability to ingest apoptotic cells and to produce several
cytokines. However, it should be pointed out that Pbx-1
is not the only transcription factor driving the apoptotic-
cell-induced IL-10 expression because deletion of Pbx1
resulted in 50% loss in IL-10 production. Moreover,
Pbx-1b is not regulated at the point of expression or phos-
phorylation by apoptotic cells nor altered in CD36-defi-
cient cells, whereas its binding to the Il10 promoter was
highly inducible. This suggests that additional, apopto-
tic-cell-induced factors that facilitate Pbx-1b binding to
DNA are involved, and these factors, not Pbx-1b itself,
might be lacking or inactive in CD36-deficient macro-
phages. In other words, CD36 does not directly regulate
Pbx-1b, and that Pbx-1b plays the role of a constitutive
but essential transcription factor for IL-10 in the apoptotic
cell pathway.
Hox proteins and some orphan homeodomain proteins
form complexes with either Pbx or Meis subclasses of
homeodomain proteins. This interaction can increase the
binding specificity and transcriptional effectiveness of
the Hox partner (Swift et al., 1998). However, Pbx has
also been shown to interact with nonhomeodomain pro-
teins such as myogenic bHLH proteins myoD and myf5
(Berkes et al., 2004). Indeed, our data indicated that
both Meis-1 and Prep-1 can enhance Pbx-1b-mediated
transcriptional activation of IL-10 gene expression in
response to apoptotic cells. Furthermore, apoptotic cells
stimulate Prep-1 tyrosine phosphorylation in a CD36-de-
pendent manner, and the DNA-binding activities by all
three Hox factors are dependent on both apoptotic-cell-
induced signaling and the presence of CD36, although
Pbx-1b itself is not regulated by these signals. These
results suggest that Prep-1 might be the bridging mole-
cule linking the two pathways, one inducible through the
CD36 contact with apoptotic cells, the other constitutive
through Pbx-1b, for IL-10 transcription. The involvement
of tyrosine phosphorylation of Prep-1 is consistent with
the observation that p38 MAPK might not be the only
kinase important for Pbx-1b binding because SB203580
could only inhibit partially Pbx-1 binding.
In summary, we demonstrate that CD36, Pbx-1b, and
Prep-1 are key regulators of IL10 gene transcription
inducedby apoptotic cells. This finding establishes a novel
link between two seemingly unrelated physiological path-
ways, one that regulates development and one that
controls autoimmune responses. This study carries the
prospect to open up a completely new area for futuremunity 27, 952–964, December 2007 ª2007 Elsevier Inc. 961
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sis and regulation of immune responses to exogenous
pathogens as well as to endogenous danger signals.
EXPERIMENTAL PROCEDURES
Animals and Cell Lines
C57BL/6 mice (6 to 8 weeks old) were purchased from the Jackson
Laboratory (Bar Harbor, ME). CD36/ mice were maintained at the
Weill Medical College of Cornell University (New York, NY). Animal
care was in accordance with National Institutes of Health (NIH) guide-
lines. Jurkat, a leukemic human T cell line, was kindly provided by G.
Koretzky of the University of Pennsylvania (Philadelphia, PA).
Reagents and Antibodies
Staurosporine was from Cayman Chemical (Ann Arbor, MI); cytochala-
sin D was from Sigma-Aldrich; (Saint Louis, MO); LPS from E. coli, Pyr-
idinyl imidazole, SB203580, and SB20247 were from Calbiochem (San
Diego, CA); antibodies against total p38, phosphorylated p38, and
phosphorylated ERK were from Cell Signaling Technology (Danver,
MA); antibodies against CD8 (TIB 210), MHC II (212.A1), Mac-1
(CD11b), NK1.1 (PK 136), and CD19 (ID3) were generously provided
by D. Sant’Angelo of the Memorial Sloan-Kettering Cancer Center
(New York, NY). PE-anti-mouse-CD36 and PE-rat IgG2a isotype con-
trol were from eBioscience, and all Pbx, Meis-1, and Prep-1 antibodies
were from Santa Cruz Biotechnologies (Santa Cruz, CA) unless
mentioned otherwise. Oxidized LDL was from INTRACELL, Frederick,
MD (cat. #RP-047).
Murine Splenic CD4+ T Cell Isolation
Enrichment of CD4+CD8 T cells from mouse spleens was performed
with DynabeadsM-450 (Dynal, Oslo, Norway). After enrichment, >75%
of the T cells were CD4+.
Human Monocytes, HMDMs, and Human T Cell Isolation
Leukocytes from healthy human donors were purchased from the New
York Blood Center. The desired subcell populations were prepared as
described (Kim et al., 2004).
Induction of Apoptosis and Necrosis
The induction of apoptosis and necrosis was as described previously
(Kim et al., 2004).
Construction of Luciferase Reporter Gene Vectors
The human IL10 promoter-luciferase construct pIL-10 (1044/+30)-
luc was generously provided by L. Ziegler-Heitbrock of the University
of Leicester (Leicester, UK) (Benkhart et al., 2000a). All subconstructs
containing deletions or base substitutions were generated by PCR and
verified by sequencing.
Transient Transfection of RAW264.7 Cells
Transfection with electroporation was performed as described previ-
ously (Cao et al., 2002).
Quantitative Real-Time PCR
Reverse transcription was performed with 2 mg total RNA and 0.2 mg of
random hexamer primers (Fermentas) in accordance with the manu-
facturer’s protocol for first synthesis of first strand cDNA. Real-time
PCR was performed with SyBr Green PCR Master Mix (Applied
Biosystem, Piscataway, NJ) containing 5 ng of cDNA mixed with pairs
of primers (10 mM) specific for IL-10 or GAPDH in a 10 ml volume. Data
were processed with GeneAmp software (Applied Biosystems, Foster
City, CA). All results were expressed as fold changes in mRNA expres-
sion relative to unstimulated cells and normalized to mGAPDH expres-
sion. Data represented the mean of triplicates.962 Immunity 27, 952–964, December 2007 ª2007 Elsevier Inc.EMSA
EMSAs were performed as described (Cao et al., 2002). The oligono-
cleotide sequences for ACRE wild-type are as follows: 50-d(AAA CCT
TGA TTG TGG CTT T)-30; ACRE mutant: 50-d(AAA CCG ATC AGA
ATG CTT T)-30, in which the critical nucleotides are in italics.
Immunoprecipitation
A total of 400 mg of whole-cell extract isolated from LPS- or apoptotic-
treated macrophages was used with various phospho-specific anti-
bodies (10 ml of anti-phospho-tyrosine, 15 ml of anti-phospho-serine,
and 30 ml of anti-phospho-threonine). After overnight incubation at
4c with rotation, 100 ml of protein A agarose beads were added into
the solution and incubated for 2 hr at 4C. The protein-bound beads
were collected, washed by PBS, and resuspended in 60 ml of 23 load-
ing buffer, and then they was resolved by SDS-PAGE, blotted, and
detected by anti-Pbx-1 or anti-Prep-1.
Phagocytosis Assay
Apoptotic Cells
Assays were as described previously (Kim et al., 2004).
E. coli
The phagocytosis assay was performed according to the manufac-
turer’s protocol (Molecular Probes, Eugene, OR; Invitrogen, Carlsbad,
CA). In brief, 0.1 3 106 of embryonic-liver-derived macrophages was
inoculated in each well of 96-well assay black plate (BD Biosciences,
San Jose, CA) in 100 ml of complete DMEM medium. After 2 hr incu-
bation at 37C to allow the cells to adhere to the microplate surface,
the culture medium was removed by aspiration, and 100 ml of pre-
pared fluorescent-labeled E. coli was added to all wells. After 2 hr
incubation, BioParticle loading suspension was removed, and 100 ml
of trypan blue was added to all of the wells. The trypan-blue suspen-
sion was aspirated after 1 min incubation at room temperature, and
then we measured the fluorescent immediately by using 480 nm
excitation,520 nm emission. We calculated the relative fluorescence
by subtracting the following from the total fluorescence taken from
wells containing both cells and E. coli (fluorescently labeled): (1) fluo-
rescence of control wells containing cells but without E. coli and (2)
fluorescence from wells containing E. coli but without cells. Each
group included four wells.
SiRNA
The siRNA for Pbx-1 was purchased from Dharmacon (Lafayette, CO).
The following is the sense sequence: 50 GGCGGAAGAGACGGAAUU
UdTdT-30 and anti-sense sequence: 50-AAAUUCCGUCUCUUCCGC
CdTdT-30. It does not discriminate the closely related Pbx-1a and
Pbx-1b isoforms. The control siRNA was specific for GFP. Transfec-
tion of siRNAwas carried out with Oligofectamine (Invitrogen) in accor-
dance with the supplier’s instructions. RAW264.7 cells, plated at 2 3
106 cell/well in six-well culture plates (Falcon), were transfected with
siRNA 4 hr prior to apoptotic cell incubation. Total whole-cell lysates,
RNA, and supernatants were harvested.
Generation of Embryonic-Liver-Derived Macrophages
Embryonic-liver-derived macrophages were generated from E14.5
embryos derived from Pbx1+/ 3 +/ mating. Genotypes of the em-
bryos were determined by PCR. Embryonic livers were gently homog-
enized into single-cell suspension, plated at 1 3 106 cells/well in
a 48-well plate, and cultured for 7 days in the presence of DMEM sup-
plemented with 20% L cell medium. Culture medium was replaced
every 3 days during the period of macrophage differentiation. Pbx-1
knockout cells lack both Pbx-1a and Pbx-1b (Moens and Selleri,
2006). These macrophages were 90% F480+ and CD11b+, as
revealed by flow-cytometric analysis.
Chromatin-Immunoprecipitation Assay
The chromatin immunoprecipitation (ChIP) procedure was performed
with a kit (Upstate Biotechnology, Lake Placid, NY) in accordance
with the manufacturer’s instructions, with 2.5 3 107 RAW264.7 cells
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200 times before PCR. The input and immunoprecipitated DNA were
PCR amplified with the primers encompassing the ARCE in the mouse
IL-10 promoter (upper primer: 50-TTTTCTACCAGCAGCAAGCA-30 and
lowerprimer: 50-ATGCTAGCTGGGTCTTGAGC-30 ). Thecontrol primers
are as follows: upper: 50-TTC CCT AGG ATC AGG GAG GT-30, and
lower: 50-AAT GGG CCT CTC TTT CCA GT-30). This pair of primers
amplifies a 230 bp fragment 1.3 kb upstreamof the ACRE. The samples
were amplified for 35 cycles (RAW264.7) or 37 cycles (primary perito-
neal macrophages) by PCR and were analyzed by electrophoresis on
a 1.2% agarose gel.
Statistical Analysis
All transfection and cytokine studies were performed in duplicates. The
results were expressed as mean ± SD from at least three independent
experiments. All statistical analyses were performed with two-tailed
Student’s t test. Data were considered significant if the p < 0.05.
Supplemental Data
Four figures are available at http://www.immunity.com/cgi/content/
full/27/6/952/DC1/.
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